Zishu Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Transcription Factor

Structure Activity Relationship

Top Venues

Journal of hepatocellular carcinoma

Future medicinal chemistry

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Changyu Ren, Zhi Cao, Yang Liu, Rui Wang, Congcong Lin, Zishu Wang
Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors. Future medicinal chemistry (2024)
Changyu Ren, Zhi Cao, Yang Liu, Rui Wang, Congcong Lin, Zishu Wang
Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors. Future medicinal chemistry 16 (16) (2024)
Honghong Shen, Xianhua Gu, Huiyuan Li, Mingyue Tang, Xinwei Li, Yue Zhang, Fang Su, Zishu Wang
Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model. Journal of hepatocellular carcinoma 10 (2023)
Xianhua Gu, Honghong Shen, Guangzheng Zhu, Xinwei Li, Yue Zhang, Rong Zhang, Fang Su, Zishu Wang
Prognostic Model and Tumor Immune Microenvironment Analysis of Complement-Related Genes in Gastric Cancer. Journal of inflammation research 16 (2023)
Honghong Shen, Xianhua Gu, Huiyuan Li, Mingyue Tang, Xinwei Li, Yue Zhang, Fang Su, Zishu Wang
Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model. Journal of hepatocellular carcinoma 10 (2023)
Xianhua Gu, Honghong Shen, Zheng Xiang, Xinwei Li, Yue Zhang, Rong Zhang, Fang Su, Zishu Wang
Exploring the Correlation Between GPR176 , a Potential Target Gene of Gastric Cancer, and Immune Cell Infiltration. Pharmacogenomics and personalized medicine 16 (2023)
Yue Zhu, Weiwei Liu, Zishu Wang, Yanfei Wang, Chaisheng Tan, Zhipeng Pan, Anqi Wang, Jiatao Liu, Guo-Ping Sun
ARHGEF2/EDN1 pathway participates in ER stress-related drug resistance of hepatocellular carcinoma by promoting angiogenesis and malignant proliferation. Cell death & disease 13 (7) (2022)
Yanyan Wang, Yue Zhang, Jiaqi Mi, Chenchen Jiang, Qiang Wang, Xinwei Li, Menglin Zhao, Zhijun Geng, Xue Song, Jing Li, Lugen Zuo, Sitang Ge, Zining Zhang, Hexin Wen, Zishu Wang, Fang Su
ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma. Oncogene 41 (29) (2022)